Myocardial Infarction Ontology

Last uploaded: February 21, 2023
Preferred Name

valsartan
Synonyms

N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-

N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine

CGP 48933

L-Valine

diovan

Definitions

An orally active nonpeptide triazole-derived antagonist of angiotensin (AT) II with antihypertensive properties. Valsartan selectively and competitively blocks the binding of angiotensin II to the AT1 subtype receptor in vascular smooth muscle and the adrenal gland, preventing AT II-mediated vasoconstriction, aldosterone synthesis and secretion, and renal reabsorption of sodium, and resulting in vasodilation, increased excretion of sodium and water, a reduction in plasma volume, and a reduction in blood pressure. [url:http://purl.obolibrary.org/obo/NCIT_C47781]

ID

http://www.semanticweb.org/admin/ontologies/2022/7/MIO:02630

definition

An orally active nonpeptide triazole-derived antagonist of angiotensin (AT) II with antihypertensive properties. Valsartan selectively and competitively blocks the binding of angiotensin II to the AT1 subtype receptor in vascular smooth muscle and the adrenal gland, preventing AT II-mediated vasoconstriction, aldosterone synthesis and secretion, and renal reabsorption of sodium, and resulting in vasodilation, increased excretion of sodium and water, a reduction in plasma volume, and a reduction in blood pressure. [url:http://purl.obolibrary.org/obo/NCIT_C47781]

label

valsartan

MIO_ID

MIO:02630

prefLabel

valsartan

reference

UMLS:C0216784

NCIT:C47781

CHEBI:9927

synonyms

N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-

N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine

CGP 48933

L-Valine

diovan

subClassOf

http://www.semanticweb.org/admin/ontologies/2022/7/MIO:02116

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.obolibrary.org/obo/XCO_0001259 XCO LOOM
https://go.drugbank.com/drugs/DB00177 MDM LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/386876001 SNOMEDCT LOOM
http://bmi.utah.edu/ontologies/hfontology/C0216784 HFO LOOM
http://www.phoc.org.cn/pmo/class/PMO_00018234 PMAPP-PMO LOOM
http://purl.bioontology.org/ontology/LNC/LP171649-9 LOINC LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C47781 NCIT LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 DRON LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 CCONT LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 DINTO LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 EFO LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 DDSS LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 BIOMODELS LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 CHEBI LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 NIFSTD LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 ECTO LOOM
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000148456 OCVDAE LOOM
http://purl.bioontology.org/ontology/NDDF/006279 NDDF LOOM
http://purl.bioontology.org/ontology/PDQ/CDR0000464172 PDQ LOOM
http://purl.bioontology.org/ontology/VANDF/4020986 VANDF LOOM
http://www.drugbank.ca/drugs/DB00177 FTC LOOM
http://purl.obolibrary.org/obo/OMIT_0001319 OMIT LOOM
http://purl.bioontology.org/ontology/RXNORM/69749 NLMVS LOOM
http://purl.bioontology.org/ontology/RXNORM/69749 RXNORM LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000148456 NDFRT LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0216784 OCHV LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#21148 OCHV LOOM
http://purl.obolibrary.org/obo/MESH_D000068756 BERO LOOM
http://purl.obolibrary.org/obo/NCIT_C47781 BERO LOOM
http://purl.bioontology.org/ontology/MESH/D000068756 MESH LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C081489 RH-MESH LOOM
http://purl.bioontology.org/ontology/ATC/C09CA03 ATC LOOM
http://purl.jp/bio/4/id/200906040213256090 IOBC LOOM
http://purl.bioontology.org/ontology/RCD/bk4.. RCD LOOM
http://www.co-ode.org/ontologies/galen#Valsartan GALEN LOOM